APA (7th ed.) Citation

Ahmed, S. H., Clark, L. L., Pennington, W. R., Webb, C. S., Bonnema, D. D., Leonardi, A. H., . . . Zile, M. R. (2006). Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease. Circulation (New York, N.Y.), 113(17), 2089-2096. https://doi.org/10.1161/CIRCULATIONAHA.105.573865

Chicago Style (17th ed.) Citation

Ahmed, S. Hinan, Leslie L. Clark, Weems R. Pennington, Carson S. Webb, D. Dirk Bonnema, Amy H. Leonardi, Catherine D. McClure, Francis G. Spinale, and Michael R. Zile. "Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease." Circulation (New York, N.Y.) 113, no. 17 (2006): 2089-2096. https://doi.org/10.1161/CIRCULATIONAHA.105.573865.

MLA (9th ed.) Citation

Ahmed, S. Hinan, et al. "Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease." Circulation (New York, N.Y.), vol. 113, no. 17, 2006, pp. 2089-2096, https://doi.org/10.1161/CIRCULATIONAHA.105.573865.